Latest News

Imprint of chemotherapy linked to inflammation in breast cancer survivors

Chemotherapy can leave a long-lasting epigenetic imprint in the DNA of breast cancer patients' blood cells. That imprint is associated with biological signs of inflammation up to six months after the completion of treatment, and many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended. Now researchers have found clues that may explain how these symptoms can linger.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Social work researchers create easier, accurate way to analyze TSCC trauma results

  • Alzheimer's culprit causes memory loss even before brain degeneration

  • Blood Pressure Medications Can Lead to Increased Risk of Stroke

  • Pembrolizumab shows real promise against head and neck cancer, study suggests

  • A patient's budding cortex -- in a dish? Networking neurons thrive in 3-D human 'organoid'

  • People with multiple sclerosis may have double the risk of dying early

  • Migraine surgery for teens: Good results in initial experience

  • Study shows how students understand mathematics

  • Parents feel racial socialization may help minority children succeed in school

  • Brain training induces lasting brain, mental health gains for veterans, civilians with brain injury

  •